Drug Type Small molecule drug |
Synonyms Pentazocine lactate (USP), Talwin |
Action agonists, antagonists |
Mechanism κ opioid receptor agonists(Kappa opioid receptor agonists), μ opioid receptor antagonists(Mu opioid receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseWithdrawn |
First Approval Date United States (24 Jul 1967), |
Regulation- |
Molecular FormulaC22H33NO4 |
InChIKeyQNLDTXPVZPRSAM-OSCGOVABSA-N |
CAS Registry17146-95-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D02111 | Pentazocine Lactate |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Acute Pain | United States | 24 Jul 1967 |